Paediatric Abacavir/Lamivudine/Dolutegravir (pALD) fixed-dose combination
Introduction and rollout planning considerations for national programmes
26 September 2023
| Technical document
Additional language version: Swahili
WHO Team
GAP-F
Number of pages
6